Literature DB >> 14594412

Estrogen plus progestin did not improve health-related quality of life in postmenopausal women 50 to 79 years of age.

Angela M Cheung1.   

Abstract

Entities:  

Year:  2003        PMID： 14594412      PMCID： PMC5224942     

Source DB:  PubMed          Journal:  ACP J Club        ISSN： 1056-8751


× No keyword cloud information.
  3 in total

1.  Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial.

Authors:  Mark A Hlatky; Derek Boothroyd; Eric Vittinghoff; Penny Sharp; Mary A Whooley
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

2.  Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial.

Authors:  G A Greendale; B A Reboussin; P Hogan; V M Barnabei; S Shumaker; S Johnson; E Barrett-Connor
Journal:  Obstet Gynecol       Date:  1998-12       Impact factor: 7.661

3.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.